These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30878948)

  • 1. Oesophageal and scaly skin lesions associated with chronic cholestatic liver disease.
    Kasper P; Goeser T; Nierhoff D
    Gut; 2019 Nov; 68(11):1960-2018. PubMed ID: 30878948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of pruritus in patients with cholestatic liver disease].
    Kremer AE; Kraus MR
    MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases.
    Arcari I; Colapietro F; Pugliese N
    Aliment Pharmacol Ther; 2024 Feb; 59(4):583-584. PubMed ID: 38247144
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists.
    Hilscher MB; Kamath PS; Eaton JE
    Mayo Clin Proc; 2020 Oct; 95(10):2263-2279. PubMed ID: 33012354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic liver disease.
    Jüngst C; Lammert F
    Dig Dis; 2013; 31(1):152-4. PubMed ID: 23797137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The skin and the liver. What is their relationship in pathology?].
    Deleixhe-Mauhin F; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 1990 Dec; 45(12):620-9. PubMed ID: 2293294
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical management of chronic cholestatic liver diseases.
    Gossard AA; Lindor KD
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():93D-98D. PubMed ID: 11110620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 69-year-old man with cholestatic liver disease.
    Jain R; McLaren B; Bejarano P; Sherman KE
    Semin Liver Dis; 1996 Nov; 16(4):445-9. PubMed ID: 9027957
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin manifestations of liver diseases.
    Koulaouzidis A; Bhat S; Moschos J
    Ann Hepatol; 2007; 6(3):181-4. PubMed ID: 17786146
    [No Abstract]   [Full Text] [Related]  

  • 10. 3.9 Nutritional Management in Cholestatic Liver Disease.
    Kloosterman E; Dijkstra T; Verkade HJ
    World Rev Nutr Diet; 2022; 124():277-284. PubMed ID: 35240641
    [No Abstract]   [Full Text] [Related]  

  • 11. [The epidemiology of cholestasis in hepatopathies].
    Budillon G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():36S-40S. PubMed ID: 7906951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The serum lipoprotein X (LP-X) test in the diagnosis of cholestatic hepatopathies (preliminary note)].
    Colalongo G; Nubile G; Fiorentini GP; Tabacchi L; Beltrandi E
    Boll Soc Ital Biol Sper; 1974 Sep; 50(18):1440-5. PubMed ID: 4458730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Icterus and cholestasis].
    Friis-Liby I; Wallerstedt S; Marschall HU
    Lakartidningen; 2012 Nov 14-20; 109(46):2093-6. PubMed ID: 23259215
    [No Abstract]   [Full Text] [Related]  

  • 14. COACH syndrome: an unusual cause of neonatal cholestasis.
    Weiland MD; Nowicki MJ; Jones JK; Giles HW
    J Pediatr; 2011 May; 158(5):858-858.e1. PubMed ID: 21237470
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers of cholestasis.
    Pieters A; Gijbels E; Cogliati B; Annaert P; Devisscher L; Vinken M
    Biomark Med; 2021 Apr; 15(6):437-454. PubMed ID: 33709780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intrahepatic cholestasis with granulomas and biliary cirrhosis. Enigmatic disease and therapeutic dilemma.
    Thomas E; Micci D
    JAMA; 1977 Jul; 238(4):337-8. PubMed ID: 577541
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases. Authors' reply.
    Thomson M; Scott A; Trost S; Lake J; Lim N
    Aliment Pharmacol Ther; 2024 Feb; 59(4):585-586. PubMed ID: 38247149
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinico-pathogenetic variants of cholestasis in different liver diseases].
    Ivashkin VT; Ivlev AS; Pliusnin SV; Vasil'ev AP
    Ter Arkh; 1992; 64(2):6-9. PubMed ID: 1509386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vulnerable esophagus: riboflavin deficiency and squamous cell dysplasia of the skin and the esophagus.
    Foy H; Kondi A
    J Natl Cancer Inst; 1984 Apr; 72(4):941-8. PubMed ID: 6584669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Carotene deficiency in cholestatic liver disease of childhood is caused by beta-carotene malabsorption.
    Socha P; Skorupa E; Pawlowska J; Wierzbicka A; Dhawan A; Jankowska I; Karczmarewicz E; Kubalska J; Lukaszkiewicz J; Lorenc R
    J Pediatr Gastroenterol Nutr; 2010 Jul; 51(1):106-9. PubMed ID: 20479682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.